Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

TrivarX Ltd

TRI.AX ✗ NOT COMPLIANT ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia Micro Cap Analyst: N/A

Last Close

$0.01

▼ -6.67%

Market Cap $11.39M · Vol 804.48K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$11.39M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

33.33

Momentum

Beta

0.90

vs Market

52W High

$0.02

56.38% below

52W Low

$0.01

93.05% above

Volume

804.48K

Avg 422.15K

P/B

0.39

Price-to-book

ROE

N/A

Return on equity

Free Float

74.67%

Public shares

Shariah Compliance8 STANDARDS

✗ TrivarX Ltd (TRI.AX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TRI.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-22.22%

-51.72%

-46.15%

YTD

-26.32%

+40.00%

-23.55%

-90.00%

Financials & Valuation

TTM · Annual

Total Revenue	$742.87K
Net Income	$-620,644.00
Revenue Growth (YoY)	-99.80%
Gross Margin	100.00%
Operating Margin	-80.57%
Net Profit Margin	-83.55%
ROE	N/A
ROA · ROIC	-7.68% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	3.51
P/B	0.39
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	1.15B

Technical Indicators

50-Day SMA	$0.01
200-Day SMA	$0.01
RSI (14)	33.33
Beta	0.90
52-Week High	$0.02
52-Week Low	$0.01

Volume Today	804.48K
Avg Daily Volume (30D)	422.15K
Relative Volume	1.91x
Volatility (10D)	91.27
Volatility (30D)	90.07
Free Float	74.67%

Analyst Consensus

N/A

Current Price $0.01

Mean Target N/A

52W Low$0.01 52W High$0.02

Current

Target

$0.01 $0.02

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001SCY1L7

ISINAU0000300196

CountryAustralia

Sub-IndustryProprietary & Advanced Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

MRK Merck & Co Inc +0.21% MRK.DE Merck KGaA -2.29% HALO Halozyme Therapeutics Inc -2.00% 4151.T Kyowa Kirin Co Ltd -1.26% 326030.KS SK Biopharmaceuticals Co Ltd -0.34%

Company Profile

TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is development of artificial intelligence (AI)-driven, scientifically based devices for screening and diagnosis of behavioral health conditions. Its clinical research has enabled the development of proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The Company’s lead product, MEB-001 analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%. Its technology analyses the electrical signals from the brain and the heart to identify mental illness.